Literature DB >> 15773695

Discrepancies between premorbid and current IQ as a function of progressive mental deterioration.

Francis McCarthy1, William J Burns, Alfred H Sellers.   

Abstract

The declining cognitive functioning typically found in patients with Alzheimer's disease presents an opportunity to study that decline. The changing magnitude of ever widening discrepancies between premorbid estimators of IQ and observed IQ increases as severity of the disease increases. Premorbid IQs estimated by these scores (the National Adult Reading Test-Revised, the reading tests of the Revised and Third Editions of the Wide Range Achievement Test, and a demographically based regression index for the Wechsler Adult Intelligence Scale-Revised) had relatively similar discrepancies from obtained WAIS-R Full Scale IQs in samples of normal elderly (n = 30), and elderly patients diagnosed with mild (n = 30) and moderate Alzheimer's disease (n = 30) dementia. The discrepancies became larger, regardless of premorbid estimator, as disease severity progressed from none to mild to moderate across the samples.

Entities:  

Mesh:

Year:  2005        PMID: 15773695     DOI: 10.2466/pms.100.1.69-76

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  3 in total

1.  Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease.

Authors:  Ian M McDonough; Gérard N Bischof; Kristen M Kennedy; Karen M Rodrigue; Michelle E Farrell; Denise C Park
Journal:  Neurobiol Aging       Date:  2016-06-25       Impact factor: 4.673

2.  Linear and nonlinear relationships between cognitive subdomains of ability discrepancy and Alzheimer's disease biomarkers.

Authors:  Ian M McDonough; Taylor E Popp
Journal:  Neuropsychology       Date:  2019-12-02       Impact factor: 3.295

3.  Cognitive differences across ethnoracial category, socioeconomic status across the Alzheimer's disease spectrum: Can an ability discrepancy score level the playing field?

Authors:  Ian M McDonough; Shameka L Cody; Erin R Harrell; Stephanie L Garrett; Taylor E Popp
Journal:  Mem Cognit       Date:  2022-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.